Skip to content

Gravitas Feeding Tube System Placement in Neonates

Gravitas Feeding Tube System Placement in Neonates

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05517707
Enrollment
16
Registered
2022-08-26
Start date
2022-11-10
Completion date
2023-08-29
Last updated
2023-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasogastric Tube

Brief summary

The purpose of this study is to optimize the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.

Interventions

DEVICENasogastric Tube

Temperature and impedance data will be collected from sensors embedded within the feeding tube wall.

Sponsors

Gravitas Medical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Weeks to 18 Weeks
Healthy volunteers
Yes

Inclusion criteria

Infants in the Newborn Intensive Care Unit requiring a 5Fr NG tube. The desired size of the feeding tube should be determined clinically, and the Gravitas 5Fr Feeding Tube should only be placed if that size is appropriate. Inclusion Criteria: * Age at enrollment: 0 to 18 weeks post-partum. Can be up to 12 weeks preterm (gestational age ≥ 28 weeks). * Suitable to start enteral feeding * Anticipated to receive enteral feeding (either bolus or continuous feeds) for more than 6 hours and conclude the enteral nutrition while in the care of the NICU. If enteral nutrition has already been initiated, indicated for replacement of an orogastric/nasogastric feeding tube.

Exclusion criteria

* Known major upper airway malformation (e.g. tracheoesophageal fistula) * Known major GI malformation (e.g. malrotation) * NPO status -neonate expected to remain NPO for the following 72 hours * Has a medical condition that drastically affects gastric acid-secretion (e.g. Zollinger-Ellison Syndrome, congenital achlorhydria, gastrointestinal perforation/leak/obstruction) * Has had removal of part of the stomach * Critically ill, facing imminent death * Neonate on ECMO * Deemed unsuitable for enrollment in study by the site principal investigator based on the patients' medical history * Ability to have a legally authorized representative provide informed consent Both neonates on a ventilator (non-invasive or invasive ventilation) or not requiring a ventilator are eligible for this study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of accurate verifications of anatomical locations of the tip of the Gravitas feeding tube.5 monthsData collected during the study will be post processed to refine the Gravitas placement algorithm. The position of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to institutional standard of care.
Percentage of accurate removals/dislodgements identified by the Gravitas dislodgement algorithm.5 monthsData collected during the study will be post processed to refine the Gravitas placement algorithm. The removal/dislodgement of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to actual removal/verification of dislodgement by institutional standard of care.
Adverse events (a) related to placement and (b) throughout the duration of the presence of the feeding tube within the patient.5 monthsThe number and type of adverse events will be collected.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026